Treatment Efficacy of 'Shinbaro Capsule' in the Treatment of Hand Osteoarthritis: Randomized, Double-blinded, Placebo-controlled, Multicenter Investigator Initiated Trial
Phase of Trial: Phase II/III
Latest Information Update: 02 Jan 2018
Price : $35 *
At a glance
- Drugs GCSB 5 (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- 02 Jan 2018 According to a GC Pharma media release, Green Cross Corporation rebrands itself to GC Pharma.
- 13 Jun 2015 Status changed from recruiting to completed, according to results presented at EULAR.
- 13 Jun 2015 Results presented at the 16th Annual Congress of the European League Against Rheumatism.